Commentary on General Court judgment of 1 July 2010 in case T-321/05 Astra Zeneca versus Commission

The Author of the article analyses the judgment of the Court of Justice in case Astra Zeneca versus Commission from 2010. It is the first judgment of the Court dealing with abuse of dominant position in pharmaceutical industry, and the first where both competition and intellectual property law have been interpreted. The reasoning of the Court is analysed from the perspective of competition law, particularly Art. 102 TFUE.